Patent · US Active

Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals

US7872034B2 · kind B2 · utility

0Cited by

12References

9Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Christian Stapper · Mainz, DE
Stefanie Keil · Frankfurt am Main, DE
Heiner Glombik · Hofheim, DE
Eugen Falk · Frankfurt am Main, DE
Jochen Goerlitzer · Frankfurt am Main, DE
Dirk Gretzke · Frankfurt am Main, DE
Hans-Ludwig Schaefer · Frankfurt am Main, DE
Wolfgang Wendler · Bad Camberg, DE

Key dates

Filing date	Jan 14, 2008
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Jan 14, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to arylcycloalkyl-substituted alkanoic acid derivatives and to their physiologically acceptable salts and physiologically functional derivatives.What is described are compounds of the formula I,in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for the treatment and/or prevention of disorders of the fatty acid metabolism and glucose utilization disorders and also disorders in which insulin resistance is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.